* Events before October 2014 were organized under the "OBR Singapore" brand
Biotech Connection Singapore along with JFDI Asia organized a Happy Hour Networking Event featuring Genome Editing. Genome Editing is the only startup from East Asia which was shortlisted for the semi-finals of OneStart Europe 2015 business plan competition.
Organized by Biotech Connection Singapore Thursday, 12 February 2015 18:30 to 21:30 (SGT) Breakthrough Theatre, Matrix Building level 4, 30 Biopolis Street, Singapore 138671
Biotech Connection Singapore organized a panel discussion and Networking Reception on Feb 12th. The topic of discussion was ‘Cell therapy Industry: What’s in it for Singapore?’
To ignite Biotech Connection’s vision for Singapore, we are honoured to have Prof. Steven Myint and A/Prof. Tan Sze Wee as our distinguished panel speakers, discussing the future of Biotech entrepreneurism in Singapore.
OneStart Europe 2015, one of the largest business competition of its kind in the world, will also be launched at the same event for the first time in Asia.
OBR-Singapore hosted a thought provoking and engaging debate to question whether patents actually help or hinder innovation. "Is patent reform necessary for the biotech industry to thrive? This House believes so."
A series of short lectures were given by key opinion figures in the Singapore Med Tech industry covering tips from an innovator entrepreneur, how to navigate Asia’s regulatory landscape, how to find funding, what investors are looking for, and how to get started. It was an evening of insightful lectures and lively discussions on Med Tech in Singapore.
The ability to write in a clear, informative and engaging way is a critical part of the scientist’s toolbox, as it allows the broader community to share in the excitement of basic scientific discovery. To nurture greater trust and generate excitement among the general public requires the engagement of science professionals who are highly trained both in their technical field of expertise as well as in the ability to communicate their discoveries to the world. This workshop was organized with a special focus on science communication as well as a career talk by a scientist working in communications.
OBR-Singapore and our panel of experts explored the potential benefits and pitfalls of Big Data in the area of healthcare and the life sciences in Singapore, with special focus on these key questions:
- With these data sets, what questions can we ask and what are we already asking?
- How can Singapore translate Big Data into clinically relevant outcomes and make money from it?
- Is the individual at risk of having their privacy invaded for the better of society?
- Where are the largest life science commercial opportunities in Big Data over the next 5 years?
Philip Yeo, the man who commissioned the Biopolis and spearheaded Singapore's efforts to establish a biomedical sciences hub spoke at OBR-Singapore's event on Tuesday 5 November.
With a reputation for being a straight-talker, risk-taker, and rule-breaker, Philip Yeo commands attention because of his wealth of experience in building Singapore's capabilities over four decades. During the seminar, he delved into stories of a richly layered past with an eye firmly fixed on the future.
OBR Singapore’s launch event brought together industry leaders, academics, entrepreneurs, venture capitalists, and policy makers in a panel discussion of key questions such as:
- For how long should we rely on a government-led approach?
- Is it time to let natural market forces shape Singapore’s biotech industry?
- Have we become overly reliant on generous government funding and how can we transition towards self-sufficiency?